[1]
Markus, U.H. et al. 2015. Survival and Side Effects of Cisplatin/Cyclophosphamide and Carboplatin/Paclitaxel Adjuvant Chemotherapy in Stage IC-IV Ovarian Cancer. Indonesian Journal of Obstetrics and Gynecology. 3, 2 (Apr. 2015), 110–116. DOI:https://doi.org/10.32771/inajog.v3i2.37.